跳至主要内容
临床试验/TCTR20160907002
TCTR20160907002招募中4 期

Efficacy of melatonin reducing weight gain in patients with schizophrenia using second generation antipsychotic drugs

Faculty of Medicine, Khonkaen University0 个研究点目标入组 50 人开始时间: 2016年9月7日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Years 至 65 Years(—)
性别
All

入选标准

  • patients who had diagnosis schizophrenia as DSM-V criteria with second generation antipsychotic drug used, age between 18-65 years old and understand the information for consent.

排除标准

  • Melatonin allergy, Renal impairment (Serum Cr > 1.5 ml/min)or Liver impairment (ALT > 100 U/L or AST> 100 U/L), pregnancy or take oral contraceptive pill, patient who use drug that inhibit CYP caused effect dose of melatonin such as omeprazole rifampicin fluvoxamine ciprofloxacin carbamazepine Modafinil. , dementia and delirium.

研究者

发起方
Faculty of Medicine, Khonkaen University

相似试验